| RS2475884746 |
DSPP
|
Health Risk |
Pathogenic |
Dentinogenesis imperfecta type 2, Dentinogenesis imperfecta type 2 |
| RS2475885470 |
DSPP
|
Health Risk |
Likely pathogenic |
Dentinogenesis imperfecta type 2, Dentinogenesis imperfecta type 2 |
| RS2475885503 |
DSPP
|
Health Risk |
Likely pathogenic |
Dentinogenesis imperfecta type 2, Dentinogenesis imperfecta type 2 |
| RS2475886228 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2475886487 |
DSPP
|
Health Risk |
Pathogenic |
Pulp calcification, Pulp calcification |
| RS2475887311 |
DSPP
|
Health Risk |
Pathogenic |
Dentinogenesis imperfecta type 2, Dentinogenesis imperfecta type 2 |
| RS2475887343 |
DSPP
|
Health Risk |
Pathogenic |
Dentinogenesis imperfecta type 2, Dentinogenesis imperfecta type 2 |
| RS2475891095 |
TRIP12
|
Health Risk |
Pathogenic |
Clark-Baraitser syndrome, Clark-Baraitser syndrome |
| RS2475895954 |
PKD2
|
Health Risk |
Pathogenic |
PKD2-related disorder, Polycystic kidney disease 2 |
| RS2475895989 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475896175 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2475901452 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475901733 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475901770 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Polycystic kidney disease 2 |
| RS2475901790 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2475901958 |
PKD2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Polycystic kidney disease 2 |
| RS2475915193 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2475915207 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475915541 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475915681 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475916022 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475916117 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475916759 |
GABRA4
|
Health Risk |
Conflicting classifications of pathogenicity |
GABRA4-associated disorder, GABRA4-associated disorder |
| RS2475925118 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475925677 |
PKD2
|
Health Risk |
Pathogenic |
PKD2-related disorder, PKD2-related disorder |
| RS2475925813 |
PKD2
|
Health Risk |
Likely pathogenic |
PKD2-related disorder, PKD2-related disorder |
| RS2475928244 |
PPP3CA
|
Health Risk |
Pathogenic |
— |
| RS2475928286 |
PPP3CA
|
Health Risk |
Pathogenic |
— |
| RS2475931922 |
ANTXR2
|
Health Risk |
Likely pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS2475935599 |
PDCD10
|
Health Risk |
Likely pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS2475935944 |
PDCD10
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 3, Cerebral cavernous malformation 3 |
| RS2475940136 |
TRIP12
|
Health Risk |
Likely pathogenic |
TRIP12-related disorder, TRIP12-related disorder |
| RS2475941629 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475941897 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2475942083 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475946632 |
TRIP12
|
Health Risk |
Pathogenic |
Clark-Baraitser syndrome, Clark-Baraitser syndrome |
| RS2475949002 |
ANTXR2
|
Health Risk |
Pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS2475951656 |
PPP3CA
|
Health Risk |
Pathogenic |
— |
| RS2475953932 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475954193 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
PKD2-related disorder, Polycystic kidney disease 2 |
| RS2475959160 |
PKD2
|
Health Risk |
Likely pathogenic |
— |
| RS2475959308 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2475959368 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475970000 |
PKD2
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease 2 |
| RS2475970181 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475970344 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475970407 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475970459 |
PKD2
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2475979108 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475979288 |
PKD2
|
Health Risk |
Pathogenic |
PKD2-related disorder, Autosomal dominant polycystic kidney disease |
| RS2475980887 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475986221 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475986648 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475986839 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475986943 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2475987388 |
TACR3
|
Health Risk |
Likely pathogenic |
TACR3-related disorder, TACR3-related disorder |
| RS2475995676 |
COL4A4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2475996480 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS2476008710 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2476008728 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2476008867 |
PKD2
|
Health Risk |
Pathogenic |
PKD2-related disorder, PKD2-related disorder |
| RS2476009603 |
PKD2
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2476011688 |
PKD2
|
Health Risk |
Pathogenic |
PKD2-related disorder, PKD2-related disorder |
| RS2476011907 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2476017155 |
TECRL
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2476023716 |
CENPE
|
Health Risk |
Likely pathogenic |
Microcephaly 13, primary |
| RS2476027523 |
TRMT10A
|
Health Risk |
Likely pathogenic |
— |
| RS2476027546 |
TRMT10A
|
Health Risk |
Pathogenic |
Microcephaly, short stature |
| RS2476032136 |
TRMT10A
|
Health Risk |
Likely pathogenic |
Microcephaly, short stature |
| RS2476038044 |
CEP135
|
Health Risk |
Likely pathogenic |
— |
| RS2476038564 |
CEP135
|
Health Risk |
Pathogenic |
— |
| RS2476055943 |
CEP135
|
Health Risk |
Pathogenic |
— |
| RS2476067663 |
TECRL
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2476074113 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476074124 |
MTTP
|
Health Risk |
Likely pathogenic |
— |
| RS2476074154 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476086631 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476086722 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476086913 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476090042 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476090084 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476090164 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476090213 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476090307 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476090399 |
MTTP
|
Health Risk |
Likely pathogenic |
— |
| RS2476093208 |
CENPE
|
Health Risk |
Likely pathogenic |
Microcephaly 13, primary |
| RS2476098813 |
TECRL
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2476098889 |
TECRL
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2476102668 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476102752 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476103063 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476106449 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476106469 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476106633 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476107655 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476107722 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476107771 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476107903 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476113390 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476113393 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |